Kenvue 3Q 2026: Revenue $3.89B, EPS $0.22— 10-Q Summary
Kenvue reported Q3 2026 net sales of $3.89B, up 3.2% YoY, with net income increasing 8% to $430M and EPS rising 4.8% to $0.22. Organic sales grew 2.9% in the quarter, with Self Care sales up 5.9% and Essential Health up 2.5%. The company aims for $200M in annual savings and is divesting feminine-care businesses as part of merger regulatory steps.
How this was made
The 30-second read
Why it matters
Traders can use the reported net sales, EPS, organic growth mix, and $200M annual gross savings target to reassess near-term margin trajectory and segment momentum. The divestiture agreements tied to the pending K-C merger add a potential future earnings and portfolio-shift overhang, though details are not provided here.
Market read
Company-specific quarterly results plus cost-savings execution are actionable for earnings and margin expectations, with segment mix showing both strength (Self Care) and softness (Skin Health and Beauty).
What to watch
The summary mentions divestiture agreements tied to the pending K-C merger, but provides no timing, valuation, or impact on future earnings, which could be a key swing factor.
Background
The piece is a brief summary of Kenvue’s 10-Q for 3Q 2026, including sales, earnings, organic growth by segment, and restructuring/savings initiatives.
Ticker impact
Kenvue reported 3Q 2026 net sales of $3.89B and diluted EPS of $0.22, plus margin support from supply-chain optimization and a $200M gross-savings initiative.
Likely modest upward bias as investors price in margin improvement from restructuring and the reported sales growth.
The article contains the company’s own 10-Q summary with specific revenue, EPS, and savings initiative details, which are actionable for earnings/margin expectations, though it is a summary rather than a full guidance update.
Market effects
Adds datapoint on consumer staples personal-care demand trends (Self Care strength, Skin Health and Beauty softness) and margin initiatives across branded hygiene.
Notes Asia Pacific outperformance in Self Care, which may inform regional demand expectations for peers.
Limited spillover beyond branded personal care, but cost-savings execution can influence sentiment toward the broader staples margin outlook.
Counterpoint
Skin Health and Beauty organic sales declined 0.5%, so the margin story may not fully offset underlying category softness.
Key entities
- companyKenvue
Reported 3Q 2026 net sales of $3.89B, diluted EPS of $0.22, and outlined restructuring-driven margin improvement with a $200M annual gross savings target.
